Mangoceuticals | ARS: Annual Report to Security Holders
Mangoceuticals | DEF 14A: Definitive information statements
Mangoceuticals | 10-Q: Quarterly report
Mangoceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mangoceuticals | EFFECT: Others
Mangoceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Mangoceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mangoceuticals | 8-K: Current report
Mangoceuticals | 8-K: Current report
Mangoceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Mangoceuticals | 8-K: Current report
Mangoceuticals | 10-K: Annual report
Mangoceuticals | 8-K: Current report
Mangoceuticals | DEF 14A: Definitive information statements
Mangoceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mangoceuticals | 8-K: Current report
Mangoceuticals | 8-K: Current report
Mangoceuticals | 8-K: Current report
Mangoceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jacob D. Cohen(42.6%),The Tiger Cub Trust(38.6%)
Mangoceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Cohen Jacob D.
No Data